SLC22A1 and polycystic ovary syndrome: Based on the findings mainly in Caucasian population STK11, SLC22A1, FSHR are potential candidate genes with SNPs that may predict drug response or resistance to commonly prescribed drugs for PCOS treatment (90, 91, 95, 97, 103, 104, 108, 110).